Unlocking Insights into Neuropsychiatric Diseases Through Genomic Research
Source-BioMed-Central A recent study spearheaded by a collaborative effort known as PsychENCODE has shed new light on the genetic underpinnings of neuropsychiatric diseases neuropsychiatric diseases such as schizophrenia and Alzheimer’s disease. The findings, published in Science on May 23, mark a significant milestone in understanding the complex relationship between genetic variation and susceptibility to these debilitating conditions. Revealing Genetic Variation in Brain Cells Led by Mark Gerstein, the Albert L. Williams Professor of Biomedical Informatics at Yale School of Medicine, the study delved into the intricate genetic landscape of brain cells. Over 2.8 million cells from the brains of 388 individuals, including those with neuropsychiatric disorders and healthy counterparts, underwent rigorous single-cell experiments. The researchers identified 28 distinct cell types and scrutinized gene expression and regulation within these cells. Unraveling Mechanisms of Disea...